Real-world evidence for amyloid-targeted therapies: Lecanemab and donanemab.

Hakim R, Harris K, Merrill L, Falk-Vargas A, Whalen E, Xia T, Ochoa O, Hunter D, Schulz PE

DOI: 10.1002/dad2.70404
Published: 2026 Jul-Sep
Container: Alzheimer's & dementia (Amsterdam, Netherlands)
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/dad2.70404,
  title = {Real-world evidence for amyloid-targeted therapies: Lecanemab and donanemab.},
  author = {Hakim R and Harris K and Merrill L and Falk-Vargas A and Whalen E and Xia T and Ochoa O and Hunter D and Schulz PE},
  year = {2026},
  journal = {Alzheimer's \& dementia (Amsterdam, Netherlands)},
  doi = {10.1002/dad2.70404},
  url = {https://doi.org/10.1002/dad2.70404}
}

RIS

TY  - JOUR
TI  - Real-world evidence for amyloid-targeted therapies: Lecanemab and donanemab.
AU  - Hakim R
AU  - Harris K
AU  - Merrill L
AU  - Falk-Vargas A
AU  - Whalen E
AU  - Xia T
AU  - Ochoa O
AU  - Hunter D
AU  - Schulz PE
PY  - 2026
JO  - Alzheimer's & dementia (Amsterdam, Netherlands)
DO  - 10.1002/dad2.70404
UR  - https://doi.org/10.1002/dad2.70404
ER  -

APA

R, H., K, H., L, M., A, F., E, W., T, X., O, O., D, H., & PE, S. (2026). Real-world evidence for amyloid-targeted therapies: Lecanemab and donanemab.. Alzheimer's & dementia (Amsterdam, Netherlands). https://doi.org/10.1002/dad2.70404

Source records

pubmed · retrieved 2026-09-25T10:23:10.666Z